Ascendis Pharma A/S develops therapies focused on improving patients' lives by addressing unmet medical needs. The company utilizes its proprietary technology to create innovative treatments in endocrinology and other therapeutic areas, aiming for sustained efficacy and improved patient outcomes.
2007
Denmark
501 - 1,000 employees
Biotechnology
$500M - 1B in revenue
Not profitable
CO2e per visit (g)
Industry benchmark